NCT00631150View on ClinicalTrials.gov

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam (Keppra)

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00631150 - A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy | Biotech Hunter | Biotech Hunter